Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.52 |
| ▸ | SMO | Q99835 | 1/20 | 0.49 |
| ▸ | KLRK1 | P26718 | 1/20 | 0.49 |
| ▸ | MICA | Q29983 | 1/20 | 0.49 |
| ▸ | RAET1L | Q5VY80 | 1/20 | 0.49 |
| ▸ | PDE2A | O00408 | 4/20 | 0.49 |
| ▸ | MTTP | P55157 | 3/20 | 0.47 |
| ▸ | APOB | P04114 | 1/20 | 0.47 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6794114 | 1.00 | TRPV1 (0.52) | TRPV1SMOKLRK1MICARAET1L | |
| SCHEMBL31739129 | 0.85 | PDE2A (0.61) | PDE2A | |
| SCHEMBL6793271 | 0.82 | TRPV1 (0.64) | TRPV1SMOMTTPAPOBGRM4 | |
| SCHEMBL6794893 | 0.81 | POLB (0.53) | TRPV1SMOMTTPAPOB | |
| SCHEMBL6796384 | 0.81 | SMO (0.55) | TRPV1SMOMTTPAPOBGRM4 | |
| SCHEMBL6792071 | 0.81 | TRPV1 (0.78) | TRPV1SMOMTTPAPOB | |
| SCHEMBL6788931 | 0.80 | TRPV1 (0.54) | TRPV1SMOMTTPAPOB | |
| SCHEMBL6792858 | 0.79 | TRPV1 (0.52) | TRPV1SMOKLRK1MICARAET1L | |
| SCHEMBL6792851 | 0.79 | TRPV1 (0.52) | TRPV1SMOKLRK1MICARAET1L | |
| SCHEMBL6793033 | 0.79 | TRPV1 (0.52) | TRPV1SMOMTTPAPOBGRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | TRPV1 3714/4885SMO 2094/4885KLRK1 1285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.